Dermot Murnaghan: Former Sky News presenter diagnosed with stage four prostate cancer
Former Sky News presenter Dermot Murnaghan has been diagnosed with prostate cancer.
The 67-year-old announced his diagnosis on social media, saying it was one of stage four "advanced" cancer.
He said he was "fortunate to have a simply outstanding medical team" looking after him that was "administering the best possible care with expertise, compassion and sensitivity".
"I'm responding positively to their excellent treatment, and feeling well," he added.
"I'm blessed to be fortified by the monumental love and support of my wife, family and close friends.
"Needless to say, my message to all men over 50, in high risk groups, or displaying symptoms, is get yourself tested and campaign for routine prostate screening by the NHS.
"Early detection is crucial. And be aware, this disease can sometimes progress rapidly without obvious symptoms."
Murnaghan said he would be taking part in charity bike ride in Glasgow in September, which aims to "shine a spotlight" on stage four cancer.
Sir Chris was himself diagnosed with stage four prostate cancer in September 2023.
Advanced prostate cancer is when the cancer cells have spread to other parts of the body, according to Macmillan Cancer Support.
Murnaghan is a familiar face to Sky News viewers as one of its main presenters from 2007 until 2023.
In September 2022, he announced the death of the late Queen Elizabeth II on the channel.
Read more from Sky News:
Before joining Sky, he presented ITV's News At Ten and the BBC Ten O'Clock News - now known as BBC News At Ten - as well as Channel 4 News.
Murnaghan also presented quiz show Eggheads on BBC Two for 11 years.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
Mounjaro becomes available on the NHS: what to know and what to do if you're not eligible
Obesity remains one of the most pressing, and preventable, health challenges of our time. The UK is one of a number of countries undoubtedly struggling with it. It affects nearly every organ system in the body, contributing to cardiovascular conditions like coronary heart disease; musculoskeletal issues such as osteoarthritis and gout; and even the development of certain cancers, including of the breast, uterus and colon. Its impact on mental health is also significant. A few years ago, injectable weight-loss drugs entered clinical use and quickly captured public attention for their ability to promote rapid fat loss. Ozempic is available on the NHS, but only for managing type 2 diabetes. Wegovy is authorised for weight loss and cardiovascular risk reduction and is also available on the NHS, though access is currently limited to specialist weight management services. Now, a new option has emerged: Mounjaro, which is approved for both type 2 diabetes and weight loss. This dual-purpose drug is now available on the NHS, offering another potential tool in the fight against obesity. Demand is expected to be high. However, access will be limited at first, with strict eligibility criteria for NHS prescriptions. Get your news from actual experts, straight to your inbox. Sign up to our daily newsletter to receive all The Conversation UK's latest coverage of news and research, from politics and business to the arts and sciences. Mounjaro (tirzepatide) is a once weekly injectable medication designed to help control blood-sugar levels. It works by boosting the secretion and effects of insulin, improving glycaemic control in people with Type 2 diabetes. It also slows gastric emptying — the process by which food leaves the stomach — and enhances feelings of fullness by acting on the brain. This combined effect reduces appetite and helps support weight loss. Compared to similar medications like Ozempic and Wegovy (both brand names for semaglutide), clinical trials found Mounjaro more effective, with some participants losing up to 20% of their body weight over a 72-week period. Read more: The NHS has introduced specific criteria to prioritise patients most in need. First, patients need a BMI of 40 or more (classified as morbid obesity). People from certain ethnic backgrounds, such as South Asian communities, may be eligible at a lower BMI due to higher clinical risk of health conditions. Second, at least four obesity-related health conditions must be diagnosed, including type 2 diabetes, hypertension (high blood pressure), dyslipidaemia (abnormal cholesterol or triglyceride levels), cardiovascular disease and obstructive sleep apnoea. (Some of these conditions often occur together; for example, high blood pressure and cholesterol.) Patients are encouraged to check their BMI and confirm their diagnoses before contacting a GP. This helps ensure appointments are used effectively and discussions remain focused. While the current criteria are strict, there is optimism that eligibility will broaden in the coming years to include people with lower BMIs and fewer co-morbidities. The NHS continues to offer a comprehensive weight-loss programme, tiered according to BMI and previous attempts at weight loss. Don't underestimate the value of group-based programmes or community referrals – when a healthcare professional refers a patient to a community-based health service for further care or support – many of which can be accessed via your GP. These services, such as the NHS digital weight management programme, support both individuals and families and can be highly effective for sustainable fat loss. GPs may also refer patients to online courses and structured exercise programmes. Lifestyle interventions, including increased physical activity and healthier eating, remain cornerstones of obesity treatment and are critical for long-term success, even when medications are used. Read more: Higher tier interventions may be considered if lifestyle changes fail or if the patient has significant co-morbidities. This is where medications like Mounjaro, or private prescriptions, may become relevant – albeit that the cost of the latter may be a limiting factor for some. Other treatments include Orlistat, a medication that reduces fat absorption in the gut. This can be effective for some but often causes unpleasant side effects, such as oily stools and gastrointestinal upset Gastric banding or surgery may also result in significant, sustained weight loss, but they come with risks, can lead to surgical complications, and recovery can be demanding It's also important to recognise that drugs like Mounjaro aren't suitable for everyone. They can cause side effects significant enough for people to stop using them, and in some cases, they may not work at all. In this new era of faster, medication-assisted weight loss, we must remember that long-term change is about more than quick fixes. Sustainable success comes from consistent effort, willingness to change and methods that are both practical and lasting. Medications can help, sometimes dramatically, but they're not the only answer. A return to basics, with tailored support and realistic goals, remains as relevant as ever. So whether you qualify for Mounjaro, are trying lifestyle changes, or are exploring other options, remember this: the journey to better health is personal, gradual and worth it. This article is republished from The Conversation under a Creative Commons license. Read the original article. Dan Baumgardt does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
Yahoo
2 hours ago
- Yahoo
First look inside new gym in north Norfolk
A new gym is opening in north Norfolk this week. With five years of experience as a personal trainer, Josh Willis and sports coach Hannah Carter are opening Carter's Gym in North Walsham on Saturday. The pair saw a "gap in the market" for weight space gyms in the area that are not bodybuilding-focused. The gym is located in Unit 16 in Robertson House (Image: Denise Bradley) The new space hopes to target those who lack confidence surrounding the use of weights. "I have a good clientele at the moment who will be joining me over here and I will continue to offer friendly service to help build people's confidence," Mr Willis said. 'We have received a really good response so far and now it is finally kicking in, the excitement is building." The gym specialises in weight training (Image: Denise Bradley) Gym goers can expect a range of weight equipment as well as cardio machines. Personal training sessions and small group classes limited to eight people to ensure "a more personalised experience" will also be on offer. "With it just being the two of us at the moment, we are a gym for our members,' Ms Carter added. Gymgoers will be able to try out the new equipment for free from 10am to 4pm on opening day (Image: Denise Bradley) "We will act on our members' feedback as we want to show them that their money is being put back into the gym." Carter's Gym is located in Unit 16 Robertson House in Laundry Loke. A monthly direct debit membership is on offer for £28.99, small group training sessions for members cost £6 and personal training is £30 an hour. Personal trainer Josh will be bringing his expertise to the new space (Image: Denise Bradley) Gymgoers will be able to try out the new equipment for free by attending the opening between 10am and 4pm on Saturday. Those who attend will be entered into a free raffle to win prizes, including a month's membership.
Yahoo
2 hours ago
- Yahoo
Royal Sources Claim Kate Middleton Will "Dramatically Scale Back" Her Responsibilities After "Wake-Up Call" Over Skipping Royal Ascot
When you buy through links on our articles, Future and its syndication partners may earn a commission. On June 18, Kate Middleton suddenly canceled a planned appearance at Royal Ascot, with sources claiming the Princess of Wales was "disappointed" to miss the event. Royal experts suggested Prince William would "feel the void" at Royal Ascot without his wife, but royal aides subsequently claimed that Kate's absence was "no cause for alarm." Now, the Daily Beast is reporting that Princess Kate's decision to skip Ascot was indicative of more serious issues. "The last few years have been horrific," a former Royal Family staff member told the outlet. "[T]he relentless speculation about her and William, Queen [Elizabeth]'s death, The King's diagnosis which had them both thinking they were going to have to take over and then her own cancer diagnosis and treatment." Unsurprisingly, the challenges Princess Kate has been dealing with have "taken [their] toll." Luckily, the Prince of Wales is standing by to "fight tooth and nail to see she is given" extra "time to recover," should she need it, per the former staff member. The former royal staff member elaborated, telling the Daily Beast, "Kate is recalibrating her entire life, her entire work-life balance. Wednesday was a wake-up call, not a one-off. She has never found the public appearances, and the forensic attention and criticism that goes with them, at all easy to deal with, and it was just too much this week." As a result of Kate's Royal Ascot cancellation, and the ensuing public reaction, experts believe the Princess of Wales will retreat from public life, to some extent. According to the Daily Beast, royal sources told the outlet "they expected Kate to dramatically scale back her public appearances for the rest of the year and instead increase her online and digital footprint, remotely supporting causes close to her heart." Essentially, Kate's health, following her cancer diagnosis and chemotherapy treatment, is more important than anything else. "Kate will take it much easier for the rest of the year," one source alleged to the outlet. "I'd be surprised if you see her more than three times in the next three months."
